{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T21:21:28Z","timestamp":1648848088325},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1991,5,1]],"date-time":"1991-05-01T00:00:00Z","timestamp":673056000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1991,5]]},"DOI":"10.1007\/bf01703149","type":"journal-article","created":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T00:31:31Z","timestamp":1118536291000},"page":"194-195","source":"Crossref","is-referenced-by-count":4,"title":["Low-dose aclarubicin in blastic transformation of essential thrombocythemia"],"prefix":"10.1007","volume":"62","author":[{"given":"Y.","family":"Asano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Naritomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kusaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01703149_CR1","doi-asserted-by":"crossref","unstructured":"Asano Y, Shimokawa M, Okabe H, Sanefuji H, Kato K (1990) Beneficial treatment with methyl 6-[3-(2-chloroethyl)-3-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in a patient with primary myelofibrosis. Acta Haematol (in press)","DOI":"10.1159\/000204866"},{"key":"BF01703149_CR2","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/1097-0142(19861201)58:11<2440::AID-CNCR2820581115>3.0.CO;2-Y","volume":"58","author":"S Bellucci","year":"1986","unstructured":"Bellucci S, Janvier M, Tobelem G, Flandrin G, Charpak Y, Berger R, Boiron M (1986) Essential thrombocythemias. Clinical evolutionary and biological data. Cancer 58: 2440\u20132447","journal-title":"Cancer"},{"key":"BF01703149_CR3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00000421-198712000-00014","volume":"10","author":"DC Case","year":"1987","unstructured":"Case DC, Ervin TJ, Boyd MA, Bove LG, Sonneborn HL, Paul SD (1987) Phase-II study of aclarubicin in acute myeloblastic leukemia. Am J Clin Oncol 10: 523\u2013526","journal-title":"Am J Clin Oncol"},{"key":"BF01703149_CR4","first-page":"177","volume":"23","author":"S Murphy","year":"1986","unstructured":"Murphy S, Iland H, Rosenthal D, Laszlo J (1986) Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol 23: 177\u2013182","journal-title":"Semin Hematol"},{"key":"BF01703149_CR5","doi-asserted-by":"crossref","first-page":"830","DOI":"10.7164\/antibiotics.28.830","volume":"28","author":"T Oki","year":"1975","unstructured":"Oki T, Matsuzawa Y, Yoshimoto A, Numata K, Kitamura I, Hori S, Takamatsu A, Umezawa H, Ishizaka M, Naganawa H, Suda H, Hamada M, Takeuchi T (1975) New antitumor antibiotics, aclacinomycins A and B. J Antibiot (Tokyo) 28: 830\u2013834","journal-title":"J Antibiot (Tokyo)"},{"key":"BF01703149_CR6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0145-2126(83)90004-8","volume":"7","author":"M Sakurai","year":"1983","unstructured":"Sakurai M, Sampi K, Hozumi M (1983) Possible differentiation of human acute myeloblastic leukemia cells by daily and intermittent administration of aclacinomycin-A. Leuk Res 7: 139\u2013143","journal-title":"Leuk Res"},{"key":"BF01703149_CR7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005792-198611000-00001","volume":"65","author":"SM Sedlacek","year":"1986","unstructured":"Sedlacek SM, Curtis JL, Weintraub J, Levin J (1986) Essential thrombocythemia and leukemic transformation. Medicine 65: 353\u2013364","journal-title":"Medicine"},{"key":"BF01703149_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0145-2126(90)90045-B","volume":"14","author":"T Shibuya","year":"1990","unstructured":"Shibuya T, Teshima T, Harada M, Taniguchi S, Okamura T, Qkamura S, Niho Y (1990) Treatment of myelodysblastic syndrome and atypical leukemia with low-dose aclarubicin. Leuk Res 14: 161\u2013167","journal-title":"Leuk Res"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01703149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01703149\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01703149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T17:14:56Z","timestamp":1586279696000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01703149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1991,5]]}},"alternative-id":["BF01703149"],"URL":"https:\/\/doi.org\/10.1007\/bf01703149","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,5]]}}}